Related references
Note: Only part of the references are listed.CD49fhigh Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors
Hiroshi Fukamachi et al.
PLOS ONE (2013)
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Phi M. Do et al.
GENES & DEVELOPMENT (2012)
CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate
Hidekazu Yamamoto et al.
PLOS ONE (2012)
CD49f Enhances Multipotency and Maintains Stemness Through the Direct Regulation of OCT4 and SOX2
Kyung-Rok Yu et al.
STEM CELLS (2012)
SIGNATURE: A workbench for gene expression signature analysis
Jeffrey T. Chang et al.
BMC BIOINFORMATICS (2011)
Enrichment of osteosarcoma stem cells by chemotherapy
Qing-Lian Tang et al.
Chinese Journal of Cancer (2011)
CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
Amit S. Adhikari et al.
CANCER RESEARCH (2010)
Osteosarcoma: Time to move on?
Stefan S. Bielack
EUROPEAN JOURNAL OF CANCER (2010)
Making gene therapy for osteosarcoma a reality
Matthew L. Broadhead et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Molecular Characterization of Commonly Used Cell Lines for Bone Tumor Research: A Trans-European EuroBoNet Effort
Laura Ottaviano et al.
GENES CHROMOSOMES & CANCER (2010)
Derivation and Characterization of an Extra-Axial Chordoma Cell Line (EACH-1) from a Scapular Tumor
Amalia M. DeComas et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2010)
Signatures of mutation and selection in the cancer genome
Graham R. Bignell et al.
NATURE (2010)
Targeting the osteosarcoma cancer stem cell
Valerie A. Siclari et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2010)
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Michael James Clark et al.
PLOS GENETICS (2010)
Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma
Padraic P. Levings et al.
CANCER RESEARCH (2009)
Strategies for the targeted delivery of therapeutics for osteosarcoma
Dennis P. M. Hughes
EXPERT OPINION ON DRUG DELIVERY (2009)
Recent advances in cancer stem cells
Robert W. Cho et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiation and leukemia inhibitory factor expression
Adam Z. Oskowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line
Massimiliano Cariati et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Current Status and Perspectives Regarding the Treatment of Osteosarcoma: Chemotherapy
Akio Sakamoto et al.
REVIEWS ON RECENT CLINICAL TRIALS (2008)
Histamine receptor H1 and dermatopontin: New downstream targets of the vitamin D receptor
Radhika R. Pochampally et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
GFP expression alters osteosarcoma cell biology
Crispin R. Dass et al.
DNA AND CELL BIOLOGY (2007)
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name?
Jiri Neuzil et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium
Kaatje Lenaerts et al.
BMC GENOMICS (2007)
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency
Lin Song et al.
STEM CELLS (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Stem-like cells in bone sarcomas: Implications for tumorigenesis
CP Gibbs et al.
NEOPLASIA (2005)
Mobilization and activation of a signaling competent alpha 6 beta 4 integrin underlies its contribution to carcinoma progression
EA Lipscomb et al.
CANCER AND METASTASIS REVIEWS (2005)
α6-integrin is expressed on germinal centre B cells and modifies growth of a B-cell line
HE Ambrose et al.
IMMUNOLOGY (2004)
Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer
MC Demetriou et al.
EXPERIMENTAL CELL RESEARCH (2004)
Share Paper
